AI agents proposed as co-scientists to accelerate biomedical drug research

Biomedical researchers are developing AI agents designed to act as autonomous 'co-scientists' in drug discovery, moving beyond AI as a passive tool. The approach aims to speed hypothesis generation and experimental design, though validation and integration into lab workflows remain uncertain. This signals a shift in how AI is applied to scientific research, potentially accelerating therapeutic development.